Advertisement

Topics

Human medicines European public assessment report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed), Revision: 30, Authorised

12:40 EST 7 Mar 2018 | European Medicines Agency

Original Article: Human medicines European public assessment report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed), Revision: 30, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed), Revision: 30, Authorised"

Advertisement
Quick Search
Advertisement
Advertisement